Pacira BioSciences (PCRX) News Today $23.74 +0.26 (+1.10%) As of 01:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock PCRX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Pacira BioSciences, Inc. (NASDAQ:PCRX) Receives $26.44 Consensus Price Target from AnalystsJune 21, 2025 | americanbankingnews.comHead to Head Analysis: Pacira BioSciences (NASDAQ:PCRX) & Antibe Therapeutics (OTCMKTS:ATBPD)June 20, 2025 | americanbankingnews.comPacira BioSciences Debuts Inspiring New Film Highlighting One Patient’s Journey to Pain Relief and Innovation in Care at BIO 2025June 18, 2025 | finance.yahoo.comPacira BioSciences, Inc. (NASDAQ:PCRX) Receives Average Rating of "Hold" from AnalystsJune 18, 2025 | marketbeat.comPACIRA ALERT: Bragar Eagel & Squire, P.C. is Investigating Pacira BioSciences, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmJune 17, 2025 | globenewswire.comPacira BioSciences, Inc. (NASDAQ:PCRX) Shares Purchased by Assenagon Asset Management S.A.June 14, 2025 | marketbeat.comGAMMA Investing LLC Grows Stock Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX)June 14, 2025 | marketbeat.comPacira Pharmaceuticals Stockholders Approve Amended Incentive PlanJune 13, 2025 | tipranks.comBridge City Capital LLC Reduces Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX)June 9, 2025 | marketbeat.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 21,781 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX)June 8, 2025 | marketbeat.comLauren Riker Sells 5,578 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX) StockJune 7, 2025 | insidertrades.comPacira BioSciences (NASDAQ:PCRX) Upgraded at Wall Street ZenJune 6, 2025 | marketbeat.comPacira BioSciences, Inc. (NASDAQ:PCRX) SVP Sells $146,199.38 in StockJune 6, 2025 | marketbeat.comPacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)June 5, 2025 | globenewswire.comWellington Management Group LLP Has $8.86 Million Stock Position in Pacira BioSciences, Inc. (NASDAQ:PCRX)June 3, 2025 | marketbeat.comPublic Employees Retirement System of Ohio Has $1.72 Million Stock Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX)June 3, 2025 | marketbeat.comTwo Sigma Advisers LP Purchases New Position in Pacira BioSciences, Inc. (NASDAQ:PCRX)June 3, 2025 | marketbeat.comTwo Sigma Investments LP Purchases 45,222 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX)June 2, 2025 | marketbeat.comQ3 EPS Estimate for Pacira BioSciences Raised by AnalystJune 2, 2025 | marketbeat.comSquarepoint Ops LLC Boosts Position in Pacira BioSciences, Inc. (NASDAQ:PCRX)June 1, 2025 | marketbeat.comVoloridge Investment Management LLC Increases Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX)May 29, 2025 | marketbeat.comPacira BioSciences, Inc. (NASDAQ:PCRX) Shares Purchased by Nuveen Asset Management LLCMay 29, 2025 | marketbeat.comAmeriprise Financial Inc. Acquires 194,597 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX)May 26, 2025 | marketbeat.comPacira BioSciences, Inc. (NASDAQ:PCRX) Receives Average Recommendation of "Hold" from BrokeragesMay 26, 2025 | marketbeat.comPacira at RBC Conference: Strategic Growth and Gene Therapy FocusMay 23, 2025 | uk.investing.comPacira BioSciences (NASDAQ:PCRX) adds US$78m to market cap in the past 7 days, though investors from three years ago are still down 57%May 22, 2025 | finance.yahoo.comGraham Capital Management L.P. Sells 61,645 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX)May 21, 2025 | marketbeat.com1,075,673 Shares in Pacira BioSciences, Inc. (NASDAQ:PCRX) Purchased by Point72 Asset Management L.P.May 20, 2025 | marketbeat.comGotham Asset Management LLC Cuts Position in Pacira BioSciences, Inc. (NASDAQ:PCRX)May 20, 2025 | marketbeat.comPacira BioSciences, Inc. (NASDAQ:PCRX) Shares Sold by Comerica BankMay 19, 2025 | marketbeat.comNorthern Trust Corp Buys 145,205 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX)May 19, 2025 | marketbeat.comNumerai GP LLC Buys Shares of 15,724 Pacira BioSciences, Inc. (NASDAQ:PCRX)May 18, 2025 | marketbeat.comBNP Paribas Financial Markets Sells 173,956 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX)May 17, 2025 | marketbeat.comJacobs Levy Equity Management Inc. Takes $8.56 Million Position in Pacira BioSciences, Inc. (NASDAQ:PCRX)May 16, 2025 | marketbeat.comPacira BioSciences, Inc. (NASDAQ:PCRX) Shares Sold by Voya Investment Management LLCMay 15, 2025 | marketbeat.comRaymond James Financial Inc. Invests $190,000 in Pacira BioSciences, Inc. (NASDAQ:PCRX)May 15, 2025 | marketbeat.comPacira BioSciences to Participate in Fireside Chat at Two Upcoming Healthcare ConferencesMay 14, 2025 | globenewswire.comPacira BioSciences, Inc. (NASDAQ:PCRX) Shares Sold by Algert Global LLCMay 13, 2025 | marketbeat.comPacira BioSciences, Inc. (NASDAQ:PCRX) Shares Sold by Cubist Systematic Strategies LLCMay 12, 2025 | marketbeat.comBokf Na Buys New Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX)May 12, 2025 | marketbeat.comBalyasny Asset Management L.P. Makes New Investment in Pacira BioSciences, Inc. (NASDAQ:PCRX)May 12, 2025 | marketbeat.comPacira BioSciences (NASDAQ:PCRX) Given New $30.00 Price Target at Needham & Company LLCMay 11, 2025 | marketbeat.comTruist Financial Sticks to Its Hold Rating for Pacira Pharmaceuticals (PCRX)May 11, 2025 | theglobeandmail.com33,813 Shares in Pacira BioSciences, Inc. (NASDAQ:PCRX) Bought by Brevan Howard Capital Management LPMay 11, 2025 | marketbeat.comAxa S.A. Buys Shares of 89,482 Pacira BioSciences, Inc. (NASDAQ:PCRX)May 11, 2025 | marketbeat.comPacira BioSciences, Inc. (NASDAQ:PCRX) Shares Sold by AQR Capital Management LLCMay 11, 2025 | marketbeat.comTudor Investment Corp ET AL Purchases New Shares in Pacira BioSciences, Inc. (NASDAQ:PCRX)May 11, 2025 | marketbeat.comEarnings call transcript: Pacira Q1 2025 shows revenue miss, stock dipsMay 10, 2025 | uk.investing.comPacira outlines growth potential with $725M-$765M 2025 revenue target and EXPAREL expansion to 2039May 10, 2025 | msn.comPacira BioSciences, Inc. (NASDAQ:PCRX) Shares Sold by Caption Management LLCMay 9, 2025 | marketbeat.com Get Pacira BioSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for PCRX and its competitors with MarketBeat's FREE daily newsletter. Email Address PCRX Media Mentions By Week PCRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PCRX News Sentiment▼1.890.91▲Average Medical News Sentiment PCRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PCRX Articles This Week▼110▲PCRX Articles Average Week Get Pacira BioSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for PCRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Perrigo News Today Supernus Pharmaceuticals News Today Omeros News Today Assembly Biosciences News Today Nektar Therapeutics News Today Cumberland Pharmaceuticals News Today Eli Lilly and Company News Today Johnson & Johnson News Today AbbVie News Today Merck & Co., Inc. News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PCRX) was last updated on 6/30/2025 by MarketBeat.com Staff From Our PartnersCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGold prediction: $5,000/oz. or higher is comingThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pacira BioSciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pacira BioSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PCRX Stock Alerts